Siltronic AG (0R8P)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 60.35 |
|---|---|
| 52-week range | 41.72 – 108.80 |
| Return, 1 month / 3 months | −18.8% / −24.7% |
| Return, 1 year / 3 years | +1.9% / −23.1% |
| Trend | Below its 200-day average |
| RSI (14) | 34 |
| Volatility (1 year) | 63.7% |
| Worst drawdown (1 year) | -45.9% |
| Average daily value traded | 2.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Siltronic AG makes hyperpure silicon wafers, the base material from which semiconductor chips are built. The company produces polished and epitaxial wafers in a range of diameters and supplies them to chip manufacturers, who use them for logic, memory and other electronic devices. Its customers are semiconductor fabricators around the world. Siltronic is based in Munich, Germany, and operates production sites in Europe, Asia and North America, serving the global microelectronics industry.
The shares are listed on the London Stock Exchange in UK under the code 0R8P, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Siltronic AG (0R8P) trades on the London Stock Exchange in UK. It last closed at EUR 60.35 on 27 October 2026.
Its price-based Market X-Ray is 34 out of 100 (a weak price profile), ranking 2,898 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.9% and over the last three months it fell 24.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 31 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -17.4% | ||
| From 52-week high | -41.9% | ||
| Momentum | 36 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -24.7% | ||
| 6-month return | -15.4% | ||
| 12-month return, skipping the last month | 25.5% | ||
| Stability (higher is calmer) | 21 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 63.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.9% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.00M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −6.2% |
|---|---|
| 1 month | −18.8% |
| 3 months | −24.7% |
| 6 months | −15.4% |
| 1 year | +1.9% |
| 3 years | −23.1% |
| 5 years | −50.1% |
Signals
| 50-day / 200-day average | 75.15 / 73.09 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.58 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 May 2025 | EUR 0.2000 |
| 14 May 2024 | EUR 1.2000 |
| 5 May 2023 | EUR 3.0000 |
| 6 May 2022 | EUR 3.0000 |
| 30 Apr 2021 | EUR 2.0000 |
| 29 Jun 2020 | EUR 3.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.